Skip to main content

Pharmaceutical Labelling (Warning Of Cognitive Function Impairment) Bill

Private Members' Bill (Presentation Bill)

Originated in the House of Commons, Session 2008-09

Last updated: 9 November 2009 at 11:38

See full passage

Long title

A Bill to make provision for a warning symbol to be prominently displayed on the packaging of pharmaceuticals which act on the brain and central nervous system so as to impair dangerously the consumer’s ability to carry out certainactivities; and for connected purposes.

Summary

The Bill would make provision for a warning symbol to be prominently displayed on the packaging of specified psychoactive pharmaceuticals, which act on the brain and central nervous system and which can impair dangerously the consumer’s ability to carry out certain activities.

Sponsor

Mr Andrew Dismore
Labour
Hendon

Current version of the Bill

13 February 2009
Commons

Bill passage

Bill started in the House of Commons
1st reading
Committee stage
Report stage
3rd reading
Bill in the House of Lords
1st reading
2nd reading
Committee stage
Report stage
3rd reading
Final stages
Consideration of amendments
Royal Assent
Key
Complete
In progress
Not applicable
Not yet reached